NCT02893098View on ClinicalTrials.gov

A Study to Evaluate the Safety and Efficacy of Humia Inj. in Patients With Symptomatic Osteoarthritis of the Knee

PHASE3CompletedINTERVENTIONAL
Enrollment

232

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

October 31, 2017

Study Completion Date

April 30, 2018

Conditions
Osteoarthritis of Knee
Interventions
DRUG

Humia inj.

"Single injection of 3mL Humia inj.~Dummy: Single injection 2ml Normal Saline inj. given weekly for 2 weeks"

DRUG

High hyal Plus inj.

Single Injection of 2mL High hyal Plus inj. given weekly for 3 weeks

Trial Locations (1)

15588

Huons, Ansan-si

All Listed Sponsors
lead

Huons Co., Ltd.

INDUSTRY

NCT02893098 - A Study to Evaluate the Safety and Efficacy of Humia Inj. in Patients With Symptomatic Osteoarthritis of the Knee | Biotech Hunter | Biotech Hunter